Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data-Reference-Cited by-同舟云学术

Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data

Published:2023-12 Issue: Volume:192 Page:104185
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Giordano Guido^ORCID,Griguolo Gaia,Landriscina Matteo,Meattini Icro,Carbone Francesco,Leone Augusto,Del Re Marzia,Fogli Stefano,Danesi Romano,Colamaria Antonio,Dieci Maria Vittoria

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference156 articles.

1. Astrocyte-endothelial interactions at the blood-brain barrier;Abbott;Nat. Rev. Neurosci.,2006

2. Leptomeningeal disease and breast cancer: the importance of tumor subtype;Abouharb;Breast Cancer Res. Treat.,2014

3. Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience;Agazaryan;Radiat. Oncol.,2021

4. Cathepsin B: multiple roles in cancer;Aggarwal;Proteom. Clin. Appl.,2014

5. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer;Akyurek;Am. J. Clin. Oncol.,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2024-01-24

2. Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center study;Therapeutic Advances in Medical Oncology;2024-01